ADITXT INC (ADTX)
US0070256047 - Common Stock
ADITXT INC
NASDAQ:ADTX (4/26/2024, 12:34:39 PM)
2.45
-0.08 (-3.16%)
Company Profile
Aditxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Richmond, Virginia and currently employs 61 full-time employees. The company went IPO on 2020-06-19. Aditxt, Inc. is a biotech company. The firm is focused on discovering, developing, and deploying health innovations. The Company’s developing and commercializing technologies with a focus on monitoring and modulating the immune system. The Company’s diverse portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing anytime and anywhere, backed by its Clinical Laboratory Improvement Amendments (CLIA) -certified and College of American Pathologists (CAP)-accredited monitoring center. Adimune, Inc’s immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues.
Company Info
ADITXT INC
737 N. Fifth Street, Suite 200
Richmond VIRGINIA 94043
P: 19094880844
CEO: Amro Albanna
Employees: 61
Website: https://aditxt.com/
ADTX News
24 days ago - Aditxt, Inc.Aditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)
a month ago - Evofem Biosciences, Inc.Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal/PRNewswire/ -- Commercial-stage women's health innovator Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced that it has successfully renegotiated the...
2 months ago - Evofem Biosciences, Inc.For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy/PRNewswire/ -- Use of GLP-1 receptor agonists, or GLP-1s, is skyrocketing in the United States, with more than nine million prescriptions for Ozempic, Wegovy,...
3 months ago - Aditxt, Inc.Aditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology Applications
3 months ago - Seeking AlphaAditxt files to sell 3.79M shares for holders (NASDAQ:ADTX)Aditxt (ADTX) files prospectus for the resale of 3.79M shares of common stock, with a statement clarifying that it is not an offer to sell securities.
4 months ago - Aditxt, Inc.Aditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 MillionADTX Twits
Here you can normally see the latest stock twits on ADTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
